Literature DB >> 15733983

The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.

Takashi Kojima1, Reiko Ishida, Murat Dogru, Eiki Goto, Yukihiro Matsumoto, Minako Kaido, Kazuo Tsubota.   

Abstract

PURPOSE: To evaluate the effectiveness of the autologous serum eyedrops in the treatment of severe dry eye patients.
DESIGN: Prospective randomized case-control study.
METHODS: Thirty-seven eyes of twenty severe dry eye patients without punctal occlusion were enrolled in this study. After 2 weeks of washout, they were randomly assigned to two groups. Group A patients used only preservative-free artificial tears, and group S patients used only autologous serum eyedrops. We evaluated the results of Schirmer test, fluorescein and rose bengal staining scores, tear film breakup time (BUT), and subjective symptom scores before and 2 weeks after treatment.
RESULTS: Mean BUT and fluorescein and rose bengal staining scores, as well as subjective symptom scores, showed significant improvement in the patients assigned to autologous serum eyedrops compared with subjects assigned to preservative-free artificial tears after 2 weeks of treatment.
CONCLUSIONS: Autologous serum eyedrops were found effective in the treatment of severe dry eye disease, as evidenced by improvement of tear stability and ocular surface vital staining scores.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733983     DOI: 10.1016/j.ajo.2004.08.040

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  53 in total

Review 1.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

2.  Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture.

Authors:  Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2011-10-22       Impact factor: 5.258

Review 3.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 4.  Therapeutic Strategies to Treat Dry Eye in an Aging Population.

Authors:  Nisreen S Ezuddin; Karam A Alawa; Anat Galor
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

5.  Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Enrico Capuzzo; Ilaria Pati; Francesca Masiello; Eva Veropalumbo; Simonetta Pupella; Stefania Vaglio; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-05       Impact factor: 3.443

Review 6.  Advances in dry eye disease treatment.

Authors:  Erin C O'Neil; Matthew Henderson; Mina Massaro-Giordano; Vatinee Y Bunya
Journal:  Curr Opin Ophthalmol       Date:  2019-05       Impact factor: 3.761

7.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

8.  The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study.

Authors:  Ali Riza Cenk Celebi; Cemalettin Ulusoy; G Ertugrul Mirza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

Review 9.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 10.  [Ophthalmological complications in Sjögren's syndrome].

Authors:  C Jacobi; C Cursiefen
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.